Clinical Trial

Retinopathy of Prematurity - Visual Function and Retinal Structure

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Children born prematurely may develop a characteristic retinal disease named retinopathy of prematurity (ROP). This disease could lead to retinal detachment and blindness. ROP was traditionally treated with laser, but injection with a medication (A-VEGF) has become more common. In this study, the researchers will explore whether treatment of ROP affects visual function and retinal development. To explore this, the study group will examine children with ROP (but not treated) with children treated with either laser or injection. The researchers will compare the children's visual functions (e.g. visual acuity and visual field) and their retinas (e.g. central and peripheral retina).
Trial Details
NCT Number NCT07427719
Lead Sponsor Oslo University Hospital
Conditions Retinopathy of Prematurity (ROP), Prematurity Complications, Cerebral Visual Impairment, Visual Field Defect
Enrollment 140 participants
Start Date 2026-04-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-23